These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 27886046)

  • 41. Confidence in nicotine for tobacco harm reduction-Bridging the policy-practice gap.
    Patwardhan S
    Drug Test Anal; 2023 Oct; 15(10):1205-1210. PubMed ID: 36413490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluating the implementation of a prescription only regulatory model for nicotine vaping products: A qualitative study on the experiences and views of healthcare professionals.
    Morphett K; Holland A; Ward S; Steadman KJ; Zwar NA; Gartner C
    Int J Drug Policy; 2024 Mar; 125():104353. PubMed ID: 38364356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Smoking cessation and reduction in people with chronic mental illness.
    Tidey JW; Miller ME
    BMJ; 2015 Sep; 351():h4065. PubMed ID: 26391240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors affecting smoking cessation efforts of people with severe mental illness: a qualitative study.
    Rae J; Pettey D; Aubry T; Stol J
    J Dual Diagn; 2015; 11(1):42-9. PubMed ID: 25491704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced Exposure to Harmful and Potentially Harmful Smoke Constituents With the Tobacco Heating System 2.1.
    Lüdicke F; Baker G; Magnette J; Picavet P; Weitkunat R
    Nicotine Tob Res; 2017 Feb; 19(2):168-175. PubMed ID: 27613951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Electronic cigarettes: harm reduction or harm prolongation?].
    Hanewinkel R
    Pneumologie; 2023 Apr; 77(4):233-238. PubMed ID: 36977471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Practitioners' Views on Nicotine Replacement Therapy in Pregnancy during Lapse and for Harm Reduction: A Qualitative Study.
    Thomson R; McDaid L; Emery J; Phillips L; Naughton F; Cooper S; Dyas J; Coleman T
    Int J Environ Res Public Health; 2019 Nov; 16(23):. PubMed ID: 31795347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tobacco, nicotine and harm reduction.
    Le Houezec J; McNeill A; Britton J
    Drug Alcohol Rev; 2011 Mar; 30(2):119-23. PubMed ID: 21375611
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [E-Cigarettes – Friend or Foe?].
    Russi EW
    Praxis (Bern 1994); 2015 Jul; 104(14):739-43. PubMed ID: 26135724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Initial ratings of different types of e-cigarettes and relationships between product appeal and nicotine delivery.
    Hajek P; Przulj D; Phillips-Waller A; Anderson R; McRobbie H
    Psychopharmacology (Berl); 2018 Apr; 235(4):1083-1092. PubMed ID: 29306962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Australian mental health care practitioners' practices and attitudes for encouraging smoking cessation and tobacco harm reduction in smokers with severe mental illness.
    Sharma R; Meurk C; Bell S; Ford P; Gartner C
    Int J Ment Health Nurs; 2018 Feb; 27(1):247-257. PubMed ID: 28160384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electronic Cigarettes in Germany: Patterns of Use and Perceived Health Improvement.
    Lehmann K; Kuhn S; Reimer J
    Eur Addict Res; 2017; 23(3):136-147. PubMed ID: 28618425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electronic nicotine delivery systems (e-cigarettes) as a smoking cessation aid: A survey among pharmacy staff in Queensland, Australia.
    Erku DA; Gartner CE; Do JT; Morphett K; Steadman KJ
    Addict Behav; 2019 Apr; 91():227-233. PubMed ID: 30224155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Managing nicotine without smoke to save lives now: Evidence for harm minimization.
    Abrams DB; Glasser AM; Villanti AC; Pearson JL; Rose S; Niaura RS
    Prev Med; 2018 Dec; 117():88-97. PubMed ID: 29944902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The old and familiar meets the new and unknown: patient and clinician perceptions on e-cigarettes for smoking reduction in UK general practice, a qualitative interview study.
    Albury C; Barnes R; Ferrey A; Coleman T; Gilbert H; Naughton F; Aveyard P; Begh R;
    Addiction; 2022 May; 117(5):1427-1437. PubMed ID: 34859526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electronic Cigarettes and Smoking Cessation in the Perioperative Period of Cardiothoracic Surgery: Views of Australian Clinicians.
    Luxton NA; Shih P; Rahman MA
    Int J Environ Res Public Health; 2018 Nov; 15(11):. PubMed ID: 30405035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biochemically verified smoking cessation and vaping beliefs among vape store customers.
    Tackett AP; Lechner WV; Meier E; Grant DM; Driskill LM; Tahirkheli NN; Wagener TL
    Addiction; 2015 May; 110(5):868-74. PubMed ID: 25675943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): The Study Protocol of an Uncontrolled Feasibility Study of Novel Nicotine Replacement Products among People Living with HIV Who Smoke.
    Bell S; Dean J; Gilks C; Boyd MA; Fitzgerald L; Mutch A; Baker P; Neilsen G; Gartner CE
    Int J Environ Res Public Health; 2017 Jul; 14(7):. PubMed ID: 28718828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Making smokers different with nicotine: NRT and quitting.
    Keane H
    Int J Drug Policy; 2013 May; 24(3):189-95. PubMed ID: 23465645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.